📰 Alpn News
Page 3 - Alpn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpn. Real-time updates on events, politics, business and more.
November 8, 2023
There's some negotiations underway between the Jeff Davis Parish Police Jury and Correct Health, a program designed for people living in correctional facilities.
November 7, 2023
By Colin Kellaher Shares of Alpine Immune Sciences fell nearly 10% in premarket trading Tuesday following the pricing of the clinical-stage immunotherapy...
November 2, 2023
By Denny Jacob Clinical stage immunotherapy company Alpine Immune Sciences shares rose 33%, to $13.96, after presenting findings on povetacicept in...
November 1, 2023
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the […]
October 9, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price fell 6.6% during trading on Monday . The company traded as low as $11.38 and last traded at $11.38. 132,540 shares changed hands during trading, a decline of 22% from the average session volume of 169,821 shares. The stock had previously closed at $12.19. […]
October 5, 2023
ALPN | Complete Alpine Immune Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
September 15, 2023
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its price objective boosted by Oppenheimer from $14.00 to $22.00 in a research report released on Monday, MarketBeat reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. Several other research firms have also issued reports on ALPN. HC Wainwright restated a buy rating and […]
September 14, 2023
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its target price lifted by Oppenheimer from $14.00 to $22.00 in a report issued on Monday, MarketBeat.com reports. They currently have an outperform rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued […]
September 14, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price was down 4.2% during mid-day trading on Tuesday . The company traded as low as $12.27 and last traded at $12.31. Approximately 16,561 shares were traded during trading, a decline of 89% from the average daily volume of 148,825 shares. The stock had previously […]
September 4, 2023
HC Wainwright reiterated their buy rating on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $17.00 price target on the biotechnology company’s stock. Separately, Wedbush boosted their target price on Alpine Immune Sciences from $17.00 to $19.00 and gave the stock […]